New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2013
05:55 EDTUBS, UBS, LAZ, LAZ, ED, ED, BLK, BLK, MRK, MRK, T, T, NYX, NYX, CPB, CPB, HES, HES, JNJ, JNJ, INTC, INTC, AA, AA, SAN, SANCapital Link to host a forum
Annual CSR Forum: CSR & IR--Maximizing Shareholder Value will be held in New York on March 13.
News For UBS;AA;INTC;JNJ;HES;CPB;NYX;T;MRK;BLK;ED;LAZ;SAN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 22, 2015
07:54 EDTHESHess Corp. upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
07:38 EDTCPBCampbell Soup revises long-term growth targets
Subscribe for More Information
07:32 EDTCPBCampbell Soup raises FY15 adjusted EPS view to $2.43-$2.46 from $2.32-$2.38
Consensus is $2.38. Consistent with previous sales guidance, the company expects sales to decline by 1 percent, reflecting the negative impact of currency translation. Reflecting favorable gross margin performance and earlier-than-expected benefits from the previously announced cost reduction initiatives, Campbell now expects adjusted EBIT to decline -2 to -1 percent, compared to the previous guidance of being at the favorable end of the -7 to -5 percent range. The company expects adjusted EPS to be in the range of -1 to 0 percent, or $2.43 to $2.46 per share, compared to the previous guidance of being at the favorable end of the -5 to -3 percent range or $2.32 to $2.38 per share.
07:31 EDTCPBCampbell Soup now sees $75M in savings from cost reduction initiatives in FY15
Subscribe for More Information
07:04 EDTMRKMerck's Keytruda approved by EU for treatment of advanced melanoma in adults
Merck announced that the European Commission has approved KEYTRUDA, the company’s anti-PD-1 therapy, for the treatment of advanced melanoma in adults. The European Commission approval of pembrolizumab is based on data from three clinical studies conducted in more than 1,500 first-line and previously-treated patients with advanced melanoma. Pembrolizumab received European Commission regulatory approval based on Phase 3 data which showed it is the first and only anti-PD-1 therapy to provide a statistically superior survival benefit as a monotherapy compared to ipilimumab, the current standard of care for advanced melanoma. Today’s approval allows marketing of pembrolizumab in all 28 EU member states at the approved dose of 2 mg/kg every three weeks. The European Commission’s approval is based on data from three studies -- KEYNOTE-001, KEYNOTE-002 and KEYNOTE-006. These studies evaluated the efficacy and safety of pembrolizumab in advanced melanoma patients – across treatment lines, prognostic factors, tumor characteristics, and BRAF mutational status – and established 2 mg/kg every three weeks as the approved dose.
06:15 EDTINTCGoogle's updated Glass to be foldable, more weather-resistant, 9to5Google says
Subscribe for More Information
06:05 EDTMRKMerck, Ablynx expand immuno-oncology collaboration
Subscribe for More Information
July 21, 2015
19:34 EDTTAT&T pleased with FCC order, sees closing DirecTV deal 'shortly' after approval
Subscribe for More Information
18:54 EDTTAT&T announces Department of Justice completed review of acquisition of DirecTV
AT&T (T) released the following statement "We are pleased the Department of Justice has completed its review of our acquisition of DIRECTV (DTV). We look forward to gaining the approval of the Federal Communications Commission so we can quickly begin providing consumers with the benefits of this combination."
18:33 EDTTFCC chairman proposes to approve AT&T-DirecTV deal with conditions
In light of news reports concerning the proposed AT&T (T) and DirecTV (DTV) transaction, FCC chairman Tom Wheeler issued the following statement: "An order recommending that the AT&T-DirecTV transaction be approved with conditions has circulated to the commissioners... If the conditions are approved by my colleagues, 12.5M customer locations will have access to a competitive high-speed fiber connection. This additional build-out is about 10 times the size of AT&T’s current fiber-to-the-premise deployment... and more than triples the number of metropolitan areas AT&T has announced plans to serve. In addition, the conditions will build on the 'Open Internet Order' already in effect... First, in order to prevent discrimination against online video competition, AT&T will not be permitted to exclude affiliated video services and content from data caps on its fixed broadband connections. Second, in order to bring greater transparency to interconnection practices, the company will be required to submit all completed interconnection agreements to the Commission, along with regular reports on network performance... We will require an independent officer to help ensure compliance with these and other proposed conditions." Reference Link
18:24 EDTTFCC poised to approve AT&T acquisition of DirecTV, WSJ reports
Subscribe for More Information
16:57 EDTTFCC poised to approve AT&T acquisition of DirecTV, DJ says
Subscribe for More Information
06:57 EDTBLKBlackRock wins license to raise funds in China, Reuters reports
Subscribe for More Information
July 20, 2015
11:39 EDTSANBanco Popular may be target in next round of Spanish bank M&A, Reuters says
Subscribe for More Information
09:34 EDTINTCActive equity options trading on open
Subscribe for More Information
09:34 EDTBLKHalliburton sees significant runway for refrack in the future
Subscribe for More Information
08:07 EDTEDConsolidated Edison CEO says interested in M&A, Bloomberg reports
Subscribe for More Information
06:56 EDTCPBCampbell Soup to host investor day
Subscribe for More Information
July 19, 2015
15:54 EDTINTCTSMC confirms 10nm mass production in 1Q17, DigiTimes says
Subscribe for More Information
14:09 EDTINTCIntel chip delay could spell opportunity or disaster, Barron's says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use